Review article · 2021 · Open access
A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors
Schizophrenia Bulletin, 47(4), 997–1006 · Published 10 February 2021 · DOI 10.1093/schbul/sbab022
In brief
“A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors” is a 2021 review article by Julia Lejeune and 2 co-authors, published in Schizophrenia Bulletin. OpenAlex counts 227 citations as of 20 November 2026, which puts it in the top 3% of works published in 2021 by citations. It is open access: the full text is free to read at Schizophrenia Bulletin.
- Citations
- 227
- Most cited in
- 2024 (67)
- Field-weighted impact
- 4.36
- References
- 46
- Authors
- 3
Abstract
The number of randomized, controlled studies of cognitive remediation (CR) for schizophrenia, a therapeutic approach designed to improve cognitive skills and function, has grown substantially over the past 20 years. Active elements of CR treatment, however, remain unknown. The current meta-analysis investigated treatment, study, and participant factors in the size of observed treatment effects. Electronic databases were searched up to May 2020 using variants of the key words "cognitive remediation," "clinical trials," and "schizophrenia." This search produced 73 unique, randomized, controlled trials. Data were independently extracted by 3 reviewers with excellent reliability. Random-effects models were used to assess primary cognitive and secondary symptom and functional outcomes. Moderator analyses investigated the role of a variety of treatment, study, and participant factors. The meta-analysis (4594 participants) revealed that CR produced significant small-to-moderate size improvements in all domains of cognition studied (Hedge's gs = .19-.33). and a significant small improvement in function (Hedge's g = .21). CR programs that included a discussion ("bridging") group to help apply acquired cognitive skills to everyday life produced larger effects on global cognition and verbal memory. CR programs with strategy-coaching produced larger effects on episodic memory. Sample age, gender, positive, negative, and overall symptoms, and medication dose did not serve as barriers to treatment gains. CR produces small-to-moderate improvements in cognition and function in schizophrenia. Programs of CR that utilize bridging groups and strategy-coaching are more cognitively potent. Future research should focus on ways to modify CR to bolster generalization of cognitive improvements to function.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lejeune, J., Northrop, A., & Kurtz, M. M. (2021). A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors. Schizophrenia Bulletin, 47(4), 997–1006. https://doi.org/10.1093/schbul/sbab022
MLA 9
Lejeune, Julia, et al. “A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors.” Schizophrenia Bulletin, vol. 47, no. 4, 2021, pp. 997–1006. https://doi.org/10.1093/schbul/sbab022.
Chicago
Lejeune, Julia, Andrew Northrop, and Matthew M. Kurtz. 2021. “A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors.” Schizophrenia Bulletin 47 (4): 997–1006. https://doi.org/10.1093/schbul/sbab022.
Harvard
Lejeune, J., Northrop, A. and Kurtz, M. M. (2021) ‘A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors’, Schizophrenia Bulletin, 47(4), pp. 997–1006. doi:10.1093/schbul/sbab022.
IEEE
J. Lejeune, A. Northrop, and M. M. Kurtz, “A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors,” Schizophrenia Bulletin, vol. 47, no. 4, pp. 997–1006, 2021, doi: 10.1093/schbul/sbab022.
BibTeX
@article{lejeune2021meta,
title = {{A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors}},
author = {Lejeune, Julia and Northrop, Andrew and Kurtz, Matthew M.},
journal = {Schizophrenia Bulletin},
year = {2021},
volume = {47},
number = {4},
pages = {997--1006},
doi = {10.1093/schbul/sbab022},
url = {https://doi.org/10.1093/schbul/sbab022}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 5 | |
| 2022 | 19 | |
| 2023 | 40 | |
| 2024 | 67 | |
| 2025 | 43 | |
| 2026 | 53 |
Its field-weighted citation impact is 4.36: it has been cited 4.36 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- cognitive remediation
- schizophrenia
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Lejeune, J., Northrop, A., & Kurtz, M. M. (2021). A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors. Schizophrenia Bulletin, 47(4), 997–1006. https://doi.org/10.1093/schbul/sbab022
How many times has this paper been cited?
227 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Schizophrenia Bulletin: sign in and open the PDF from this page.
Who wrote this paper?
Julia Lejeune, Andrew Northrop, Matthew M. Kurtz.
What is the DOI of this paper?
10.1093/schbul/sbab022, permanently at https://doi.org/10.1093/schbul/sbab022. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.